Parallax Volatility Advisers, L.P. Bridge Bio Pharma, Inc. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $996 - $1,350	-75 Reduced 17.05%	365 $6,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $3,154 - $8,162	440 New	440 $7,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $2.77 Million - $3.8 Million	-59,134 Reduced 68.12%	27,671 $1.3 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $92,103 - $126,709	1,982 Added 2.34%	86,805 $5.29 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $4.71 Million - $6.14 Million	84,823 New	84,823 $5.23 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.08B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.